Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision was updated to v3.5.4, replacing the previous v3.5.3. This indicates a new version of the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check25 days agoChange DetectedNo additions or deletions are listed in the changes source for this page; therefore, no specific edits are captured. If updates were present, they would appear as textual changes to study details, eligibility, or locations.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page’s footer version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a site release/update rather than any change to the clinical trial study content.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page revision is updated to v3.5.2; the previous revision v3.5.0 has been removed.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page shows a new revision version, updating from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.